Abstract
Background
The prevalence and cost of unnecessary advanced imaging studies (AIS) in the evaluation of long bone cartilaginous lesions have not been studied previously.
Methods
A total of 105 enchondromas and 19 chondrosarcomas arising in long bones from July 2008 until April 2012 in 121 patients were reviewed. Advanced imaging was defined as MRI, CT, bone scan, skeletal survey, or CT biopsy. Two blinded radiologists independently reviewed the initial imaging study and determined if further imaging was indicated based on that imaging study alone. The cost of imaging was taken from our institution’s global charge list. Imaging was deemed unnecessary if it was not recommended by our radiologists after review of the initial imaging study. The difference in cost was calculated by subtracting the cost of imaging recommended by each radiologist from the cost of unnecessary imaging. The sensitivity and specificity for distinguishing enchondromas from chondrosarcomas was calculated. A minimum of 2 years from diagnosis of an enchondroma was required to monitor for malignant transformation.
Results
Of patients diagnosed with an enchondroma, 85 % presented with AIS. The average enchondroma patient presented with one unnecessary AIS. The radiologists’ interpretations agreed 85 % of the time for enchondromas and 100 % for chondrosarcomas. The sensitivity and specificity for distinguishing enchondromas from chondrosarcomas was 95 % for one radiologist and 87 and 95 % for the other. The average unnecessary cost per enchondroma patient was $1,346.18.
Conclusions
Unnecessary AIS are frequently performed and are a significant source of expense. The imaging algorithms outlined in this study may reduce unnecessary AIS.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Campanacci M. Bone and soft tissue tumors. New York: Springer; 1990.
Choi BB, Jee WH, Sunwoo HJ, Cho JH, Kim JY, Chun KA, Hong SJ, Chung HW, Sung MS, Lee YS, Chung YG. MR differentiation of low-grade chondrosarcoma from enchondroma. Clin Imaging. 2013;37:542–7.
De Beuckeleer LH, De Schepper AM, Ramon F. Magnetic resonance imaging of cartilaginous tumors: is it useful or necessary? Skelet Radiol. 1996;25:137–41.
Dorman DD, Bogdan C. Bone tumors. St. Louis: Mosby; 1998.
Eefting, D, Schrage Y, Geirnaerdt M, Le Cessie S, Taminiau A, Bovee J, Hogendoorn P. Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilagenous tumors. Am J Surg Pathol. 2009;33(1):50–7.
Espeland A, Natvig NL, Løge I, Engebretsen L, Ellingsen J. Magnetic resonance imaging of the knee in Norway 2002-2004 (national survey): rapid increase, older patients, large geographic differences. BMC Health Serv Res. 2007;22:7:115.
Ferrer-Santacreu EM, Ortiz-Cruz EJ, Gonzalez-Lopez JM, Fernandez EP. Enchondroma versus low-grade chondrosarcoma in appendicular skeleton: clinical and radiological criteria. J Oncol. 2012;2012:437958.
Geirnaerdt MJ, Hermans J, Bloem JL, Kroon HM, Pope TL, Taminiau AH, Hogendoorn PC. Usefulness of radiography in differentiating enchondroma from central grade 1 chondrosarcoma. AJR Am J Roentgenol. 1997;169:1097–104.
Hong ED, Carrino JA, Weber KL, Fayad LM. Prevalence of shoulder enchondromas on routine MR imaging. Clin Imaging. 2011;35:378–84.
Inglehart JK. Health insurers and medical-imaging policy -a work in progress. N Engl J Med. 2009;360:1030–7.
Kendell SD, Collins MS, Adkins MC, Sundaram M, Unni KK. Radiographic differentiation of enchondroma from low-grade chondrosarcoma in the fibula. Skelet Radiol. 2004;33:458–66.
Kobayashi H, Kotoura Y, Hosono M, Sakahara H, Hosono M, Yao ZS, Tsuboyama T, Yamamuro T, Endo K, Konishi J. Diagnostic value of Tc-99 m (V) DMSA for chondrogenic tumors with positive Tc-99 m HMDP uptake on bone scintigraphy. Clin Nucl Med. 1995;20:361–4.
Lee FY, Yu J, Chang SS, Fawwaz R, Parisien MV. Diagnostic value and limitations of fluorine-18 fluorodeoxyglucose positron emission tomography for cartilaginous tumors of bone. J Bone Joint Surg Am. 2004;86:2677–85.
Miller RA, Sampson NR, Flynn JM. The prevalence of defensive orthopaedic imaging: a prospective practice audit in Pennsylvania. J Bone Joint Surg Am. 2012;94:e18.
Mirra JM. Intramedullary cartilage and chondroid-producing tumors. In: Mirra JM ed. Bone tumors: clinical, radiologic, and pathologic correlations. Philadelphia: Lea & Febiger; 1989:439–535.
Murphey MD, Flemming DJ, Boyea SR, Bojescul JA, Sweet DE, Temple HT. Enchondroma versus chondrosarcoma in the appendicular skeleton: differentiating features. Radiographics. 1998;18:1213–37.
Parlier-Cuau C, Bousson V, Ogilvie CM, Lackman RD, Laredo JD. When should we biopsy a solitary central cartilaginous tumor of long bones? Literature review and management proposal. Eur J Radiol. 2011;77:6–12.
Sethi MK, Obremskey WT, Natividad H, Mir HR, Jahangir AA. Incidence and costs of defensive medicine among orthopedic surgeons in the United States: a national survey study. Am J Orthop. 2012;41:69–73.
Skeletal Lesions Interobserver Correlation among Expert Diagnosticians (SLICED) Study Group. Reliability of histopathologic and radiologic grading of cartilaginous neoplasms in long bones. J Bone Joint Surg Am. 2007;89(10):2113–23.
Smith-Bindman R, Miglioretti DL, Johnson E, Lee C, Feigelson HS, Flynn M, Greenlee RT, Kruger RL, Hornbrook MC, Roblin D, Solberg LI, Vanneman N, Weinmann N, Williams AE. Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. JAMA. 2012;307(22):2400–9.
Statistics Norway. Statistical yearbook of Norway 2004. Available at: http://www.ssb.no/a/en/histstat/aarbok/2004_en.pdf. Accessed 16 Jan 2014.
United States Census Bureau. Annual Estimates of the Resident Population for the United States, Regions, States, and Puerto Rico: April 1, 2010 to July 1, 2013. http://www.census.gov/popest/data/state/totals/2013/index.html. Accessed 16 Jan 2014.
Unni KK. Dahlin’s bone tumors: general aspects and data on 11,087 cases, 5th edn. Philadelphia: Lippincott-Raven; 1996.
Vanel D, Kreshak J, Larousserie F, Alberghini M, Mirra J, De Paolis M, Picci P. Enchondroma vs. chondrosarcoma: a simple, easy-to-use, new magnetic resonance sign. Eur J Radiol. 2013;82:2154–60.
Varma DG, Ayala AG, Carrasco CH, Guo SQ, Kumar R, Edeiken J. Chondrosarcoma: MR imaging with pathologic correlation. Radiographics. 1992;12:687–704.
Walden MJ, Murphey MD, Vidal JA. Incidental enchondromas of the knee. AJR Am J Roentgenol. 2008;190:1611–5.
World Health Organization Global Health Expenditure Atlas. 2010 statistics. http://www.who.int/nha/atlas.pdf. Accessed January 16, 2014.
Acknowledgment
The authors thank Lisa Raines for providing financial data. No outside source of funding was used for this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wilson, R.J., Zumsteg, J.W., Hartley, K.A. et al. Overutilization and Cost of Advanced Imaging for Long-Bone Cartilaginous Lesions. Ann Surg Oncol 22, 3466–3473 (2015). https://doi.org/10.1245/s10434-014-4325-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-014-4325-y